A Study of Tasisulam-sodium Versus Paclitaxel as Treatment for Metastatic Melanoma
Clinical trial NCT01006252 · TERMINATED
Trial details
- NCT number
- NCT01006252
- Sponsor
- Eli Lilly and Company
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-12-01
- Primary completion
- 2011-03-01
- Enrollment
- 336
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.